Migraine Nasal Spray Market

Segmentation by Drug Type (Ergotamine Dihydroergotamine, Ketorolac, and Zolmitriptan); by Distribution Channel (Hospital Pharmacies, Online Drug Store, and Retail Pharmacies); and by Dosage (5 mg, 10 mg, 20 mg, and 40 mg) – Global Demand Analysis & Opportunity Outlook 2031

Buy Now
Report ID: 4059 | Published On: Feb 16, 2023
Request Free Sample Copy

Global Migraine Nasal Spray Market Regional Synopsis

Regionally, the global migraine nasal spray market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region witnessed modest growth over the forecast period on the back of increasing cases of migraine, raising awareness, and developing health care infrastructure. According to the report published in U.S. National Library for Medicine, migraine continues to be an important public health problem prevalent among 15.9% of all adults in the year 2018. Moreover, around 40% of US adults with migraine were unemployed in the same year. Hence, the governments in developed nations are addressing the disadvantages of migraines and making people aware of remedies, such as, migraine nasal spray, which is estimated to boost the market growth.

The market in the Asia Pacific region is expected to expand significantly over the forecast period. Highly populated countries such as India, China, and others, are estimated to offer a large consumer base for migraine nasal sprays, owing to the increasing cases of migraine in the region.

Migraine Nasal Spray Market Share Image

Get more information on this report: Request Sample PDF

The global migraine nasal spray market is further classified on the basis of region as follows: 

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook 

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook 

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook 

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook 

  • The Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook 

Migraine Nasal Spray Market Graph
Get more information on this report: Request Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth

Global Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centres for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Market Segmentation 

Our in-depth analysis of the global migraine nasal spray market includes the following segments:  

By Drug Type 

  • Ergotamine Dihydroergotamine
  • Ketorolac
  • Zolmitriptan

By Distribution Channel

  • Hospital Pharmacies
  • Online Drug Store
  • Retail Pharmacies

By Dosage

  • 5 mg
  • 10 mg
  • 20 mg
  • 40 mg

Growth Drivers  

  • Changing Lifestyle of People

  • Increase in Stress, Anxiety, and Consumption of Adulterated Food


  • Higher Adoption of Medicine over Spray
  • Side Effects, such as, Dry and Burning Eyes, and Sore Throat

Global Healthcare Expenditure per Capita Graph
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Upsher-Smith Laboratories, LLC
      • Company Overview 
      • Business Strategy 
      • Key Product Offerings 
      • Financial Performance 
      • Key Performance Indicators 
      • Risk Analysis 
      • Recent Development 
      • Regional Presence 
      • SWOT Analysis 
    • Dr. Reddy’s Laboratories Ltd.
    • AstraZeneca PLC
    • GlaxoSmithKline plc
    • Leucadia Pharmaceuticals (Custopharm, Inc.)
    • Assertio Therapeutics, Inc
    • Cipla Inc.
    • Impel Neuro Pharma.Inc
    • Tonix Pharmaceuticals Holding Corp.
    • Amneal Pharmaceuticals LLC 

In The News

  • March 22, 2022: Impel NeuroPharma, the manufacturer of migraine nasal spray Trudhesa, presented drug performance data at the 2022 scientific meeting of the American Academy of Neurology. The latest data shows rapid and consistent migraine relief with Trudhesa treatment.

  • June 7, 2017: AstraZeneca endorsed an agreement with Grunenthal to divest rights of the migraine treatment Zolmitriptan. Grunenthal will attain the rights to market the drug outside Japan, including the United States.

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the migraine nasal spray market?

Ans: The exponentially increasing number of migraine patients worldwide is the leading cause of the widening demand for migraine nasal sprays.

2) What would be the CAGR of migraine nasal spray market over the forecast period?

Ans: The market is anticipated to attain a notable CAGR over the forecast period, i.e., 2022-2031.

3) What are the challenges affecting the migraine nasal spray market growth?

Ans: People often experience side effects such as unusual taste in the mouth, dizziness, and dry eyes. These adverse effects are estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of migraine nasal spray market in future?

Ans: North America region is estimated to provide a good business opportunity for the market on account of good healthcare infrastructure and rising awareness among people.

5) Who are the major players dominating the migraine nasal spray market?

Ans: The major players in the market are Upsher-Smith Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Cipla Inc, Dr. Reddy’s Laboratories Ltd, Assertio Therapeutics, Inc., and Impel Neuro Pharma. Inc.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company, which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the migraine nasal spray market?

Ans: The market is segmented by drug type, distribution channel, dosage, and by region.

8) Which sub-segment captures the largest market size in the drug type segment in the migraine nasal spray market?

Ans: The zolmitriptan segment is anticipated to hold the largest market size in value and is estimated to grow at a high CAGR over the forecast period.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample